AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figure at a giant checklist

8 tips for strengthening your AMA Joy in Medicine application

| 14 Min Read
Businessperson signs documents while collaborating with a colleague

A strong advising team can help your private practice flourish

| 6 Min Read
Fruits and vegetables surround smartphone

Ditching the “SAD plate” to prevent and control chronic disease

| 7 Min Read
Margaretta Masse, MD, featured on "Health vs. Hype" AMA podcast

6 things patients should know about red light therapy

| 5 Min Read